ESC 365 - Professor Horng Chen

Speaker illustration

Professor Horng Chen

Mayo Clinic, Rochester (United States of America)

Member of:

Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Pharmacological management of hypertension

Diabetes mellitus is a predictor of development of heart failure independent of HTN, CAD and diastolic function: a population based study

Event: Heart Failure 2019

Topic: Diabetes and the Heart

Session: Risk factors and prevention

Novel Designer Natriuretic Peptide (ZD100) in Human Resistant-Like Hypertension - A First in Human Study

Event: ESC Congress 2016

Topic: Treatment of hypertension

Session: Resistant hypertension

Diastolic dysfunction has differential impact on clinical outcomes of diabetic versus non-diabetic patients hospitalized with acute heart failure: a population based study

Event: HEART FAILURE 2016

Topic: Acute heart failure (other)

Session: Acute heart failure

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources